Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of gemcitabine hydrochloride, cisplatin, nab-paclitaxel, and durvalumab for locally advanced or metastatic gallb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Durvalumab (durvalumab)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Fudan University | Conditions: Gallbladder Cancer Unresectable | Phase 2 | Status: NOT_YET_RECRUITING